C39H51N3O3S — CID 67776277
4-[(1R,3aS,5aR,5bR,7aR,11aS,11bR,13aR,13bR)-5a,5b,8,8,11a-pentamethyl-1-prop-1-en-2-yl-3a-(1,3,4-thiadiazol-2-ylcarbamoyl)-1,2,3,4,5,6,7,7a,11,11b,12,13,13a,13b-tetradecahydrocyclopenta[a]chrysen-9-yl]benzoic acid (PubChem CID 67776277) has the molecular formula C39H51N3O3S and a molecular weight of 641.92 g/mol. Its IUPAC name is 4-[(1R,3aS,5aR,5bR,7aR,11aS,11bR,13aR,13bR)-5a,5b,8,8,11a-pentamethyl-1-prop-1-en-2-yl-3a-(1,3,4-thiadiazol-2-ylcarbamoyl)-1,2,3,4,5,6,7,7a,11,11b,12,13,13a,13b-tetradecahydrocyclopenta[a]chrysen-9-yl]benzoic acid.
| Compound Name | 4-[(1R,3aS,5aR,5bR,7aR,11aS,11bR,13aR,13bR)-5a,5b,8,8,11a-pentamethyl-1-prop-1-en-2-yl-3a-(1,3,4-thiadiazol-2-ylcarbamoyl)-1,2,3,4,5,6,7,7a,11,11b,12,13,13a,13b-tetradecahydrocyclopenta[a]chrysen-9-yl]benzoic acid |
|---|---|
| PubChem CID | 67776277 |
| Molecular Formula | C39H51N3O3S |
| Molecular Weight | 641.92 g/mol |
| Exact Mass | 641.37 |
| IUPAC Name | 4-[(1R,3aS,5aR,5bR,7aR,11aS,11bR,13aR,13bR)-5a,5b,8,8,11a-pentamethyl-1-prop-1-en-2-yl-3a-(1,3,4-thiadiazol-2-ylcarbamoyl)-1,2,3,4,5,6,7,7a,11,11b,12,13,13a,13b-tetradecahydrocyclopenta[a]chrysen-9-yl]benzoic acid |
| SMILES | C=C(C)[C@@H]1CC[C@]2(C(=O)Nc3nncs3)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC=C(c6ccc(C(=O)O)cc6)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12 |
| InChI | InChI=1S/C39H51N3O3S/c1-23(2)26-14-19-39(33(45)41-34-42-40-22-46-34)21-20-37(6)28(31(26)39)12-13-30-36(5)17-15-27(24-8-10-25(11-9-24)32(43)44)35(3,4)29(36)16-18-38(30,37)7/h8-11,15,22,26,28-31H,1,12-14,16-21H2,2-7H3,(H,43,44)(H,41,42,45)/t26-,28+,29-,30+,31+,36-,37+,38+,39-/m0/s1 |
| InChIKey | HBQNBVRDYIMTRX-LWVALZDHSA-N |
| XLogP | 9.53 |
| TPSA | 92.18 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 46 |
| Complexity | — |
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 641.92 |
| LogP ≤ 5 | 9.53 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 5 |
| Structural Alerts | {'alert_name': 'isolated_alkene', 'substructure': 'N/A'} |
|---|